Dec 20 (Reuters) - Medadvisor Ltd MDR.AX:
TRADING UPDATE AND INVESTOR BRIEFING
SEES SHIFT OF REVENUE FROM FIRST HALF TO SECOND HALF IN ITS US BUSINESS
FIRST HALF FY25 REVENUE EXPECTED TO BE DOWN 25-30%
EBITDA IS EXPECTED TO REMAIN POSITIVE FOR FIRST HALF AND FULL YEAR FY25.
Further company coverage: MDR.AX
((Reuters.Briefs@thomsonreuters.com;))